PCVX Vaxcyte, Inc. Stock Quote

PCVX [NASD]

Index	-	P/E	-	EPS (ttm)	-	Insider Own	1.50%	Shs Outstand	50.90M	Perf Week	-6.27%
Market Cap	1.29B	Forward P/E	-	EPS next Y	-2.58	Insider Trans	-63.82%	Shs Float	41.85M	Perf Month	-5.52%
Income	-	PEG	-	EPS next Q	-0.54	Inst Own	89.70%	Short Float	8.02%	Perf Quarter	-17.50%
Sales	-	P/S	-	EPS this Y	-70.50%	Inst Trans	4.16%	Short Ratio	9.05	Perf Half Y	-45.92%
Book/sh	7.15	P/B	3.30	EPS next Y	59.20%	ROA	-	Target Price	-	Perf Year	-
Cash/sh	7.29	P/C	3.24	EPS next 5Y	11.80%	ROE	-	52W Range	17.80 - 58.47	Perf YTD	-11.10%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-60.55%	Beta	-
Dividend %	-	Quick Ratio	10.10	Sales past 5Y	-	Gross Margin	-	52W Low	29.61%	ATR	1.99
Employees	43	Current Ratio	10.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	40.73	Volatility	8.91% 8.11%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	85.70%	Profit Margin	-	Rel Volume	1.32	Prev Close	23.62
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	370.90K	Price	23.07
Recom	1.60	SMA20	-9.83%	SMA50	-11.53%	SMA200	-34.26%	Volume	373,727	Change	-2.33%

Jul-07-20

Initiated

Needham

Buy

$40

Jul-07-20

Initiated

Cantor Fitzgerald

Overweight

$55

Jul-07-20

Initiated

BofA Securities

Buy

$37

Jan-06-21 08:15AM	Vaxcyte Announces Publication of Preclinical Proof-of-Concept Data Supporting Potential of VAX-A1, a Novel Conjugate Vaccine Designed to Prevent Group A Strep Infections GlobeNewswire +6.58%
Dec-22-20 08:00AM	Vaxcyte Promotes Andrew Guggenhime to President and Chief Financial Officer GlobeNewswire
Dec-10-20 06:34PM	Is PCVX A Good Stock To Buy Now? Insider Monkey
Nov-24-20 04:05PM	Vaxcyte to Present at Evercore ISI 3rd Annual HealthCONx Conference GlobeNewswire
Nov-12-20 04:15PM	Vaxcyte Reports Third Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Nov-10-20 04:41PM	Vaxcyte to Present at Jefferies Virtual London Healthcare Conference GlobeNewswire
Sep-23-20 07:00AM	Longitude Capital Raises $585 Million Fund to Invest in Transformative Healthcare Companies GlobeNewswire
Sep-14-20 02:27PM	We're Interested To See How Vaxcyte (NASDAQ:PCVX) Uses Its Cash Hoard To Grow Simply Wall St.
Sep-09-20 05:28PM	Vaxcyte to Present at 2020 Cantor Virtual Global Healthcare Conference GlobeNewswire
Aug-14-20 03:01PM	Dow Jones Edges Higher In New Bid For 28,000; Tesla, AMAT Stock Lead Nasdaq Investor's Business Daily +8.71%
Aug-12-20 04:59PM	CORRECTION Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire +8.00%
04:10PM	Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update GlobeNewswire
Jun-16-20 04:05PM	Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire +15.36%
Jun-12-20 11:24AM	Vaccine maker Vaxcyte's shares soar 22% in trading debut MarketWatch
06:18AM	Vaccine maker Vaxcyte upsizes IPO and prices at top end of range MarketWatch
01:06AM	Vaxcyte Announces Pricing of Upsized Initial Public Offering GlobeNewswire
Jun-03-20 08:30AM	Vaxcyte Appoints Halley E. Gilbert to Board of Directors GlobeNewswire
May-21-20 08:30AM	SutroVax Announces Name Change to Vaxcyte GlobeNewswire

Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging strains causing significant invasive pneumococcal disease and antibiotic resistance; VAX-A1, a conjugate vaccine candidate for protection against subtypes of Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting porphyromonas gingivalis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was founded in 2013 and is headquartered in Foster City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Fairman Jeff	VP, Research	Feb 26	Option Exercise	0.04	4,750	190	6,158	Mar 02 05:37 PM
Fairman Jeff	VP, Research	Feb 26	Sale	23.93	4,750	113,663	1,408	Mar 02 05:37 PM
PICKERING GRANT	President & CEO	Feb 22	Option Exercise	1.79	15,000	26,850	593,691	Feb 24 04:23 PM
Wassil Jim	Chief Operating Officer	Feb 22	Option Exercise	2.42	3,000	7,260	19,381	Feb 24 04:25 PM
Wassil Jim	Chief Operating Officer	Feb 22	Sale	26.77	3,000	80,299	16,381	Feb 24 04:25 PM
PICKERING GRANT	President & CEO	Feb 22	Sale	26.47	15,000	397,036	578,691	Feb 24 04:23 PM
Wright-Mitchell Jane	General Counsel	Feb 16	Option Exercise	2.03	2,500	5,075	4,062	Feb 17 04:55 PM
Wright-Mitchell Jane	General Counsel	Feb 16	Sale	26.95	2,500	67,375	1,562	Feb 17 04:55 PM
Sauer Paul	SVP Process Dev, Manufacturing	Feb 11	Option Exercise	1.79	2,500	4,475	80,399	Feb 16 07:46 PM
Sauer Paul	SVP Process Dev, Manufacturing	Feb 11	Sale	26.65	2,500	66,624	77,899	Feb 16 07:46 PM
Hopfner Robert Lorne	Director	Feb 10	Sale	26.53	78,158	2,073,658	1,405,418	Feb 10 07:22 PM
Hopfner Robert Lorne	Director	Feb 09	Sale	28.19	220,744	6,223,692	1,483,576	Feb 10 07:22 PM
Hopfner Robert Lorne	Director	Feb 08	Sale	25.79	79,796	2,058,117	1,704,320	Feb 10 07:22 PM
Hopfner Robert Lorne	Director	Feb 03	Sale	25.06	2,768	69,366	1,784,116	Feb 04 08:51 PM
Hopfner Robert Lorne	Director	Feb 02	Sale	25.13	14,234	357,700	1,786,884	Feb 04 08:51 PM
Hopfner Robert Lorne	Director	Jan 28	Sale	25.07	2,000	50,140	1,801,118	Feb 02 12:17 PM
Hopfner Robert Lorne	Director	Jan 27	Sale	25.30	2,140	54,142	1,803,118	Jan 27 06:02 PM
Fairman Jeff	VP, Research	Jan 26	Option Exercise	0.04	4,750	190	6,158	Jan 28 04:36 PM
Fairman Jeff	VP, Research	Jan 26	Sale	25.27	4,750	120,014	1,408	Jan 28 04:36 PM
Hopfner Robert Lorne	Director	Jan 26	Sale	25.30	18,142	458,958	1,805,258	Jan 27 06:02 PM
Hopfner Robert Lorne	Director	Jan 25	Sale	25.81	34,972	902,745	1,823,400	Jan 27 06:02 PM
Hopfner Robert Lorne	Director	Jan 22	Sale	25.16	11,383	286,396	1,858,372	Jan 22 06:10 PM
Hopfner Robert Lorne	Director	Jan 21	Sale	25.11	100	2,511	1,869,755	Jan 22 06:10 PM
Wassil Jim	Chief Operating Officer	Jan 20	Option Exercise	2.42	3,000	7,260	19,381	Jan 21 07:12 PM
Wassil Jim	Chief Operating Officer	Jan 20	Sale	25.50	3,000	76,500	16,381	Jan 21 07:12 PM
Hopfner Robert Lorne	Director	Jan 20	Sale	25.35	19,046	482,816	1,869,855	Jan 22 06:10 PM
PICKERING GRANT	President & CEO	Jan 19	Option Exercise	1.79	15,000	26,850	593,691	Jan 21 06:58 PM
PICKERING GRANT	President & CEO	Jan 19	Sale	25.10	15,000	376,498	578,691	Jan 21 06:58 PM
Hopfner Robert Lorne	Director	Jan 19	Sale	25.62	49,516	1,268,634	1,888,901	Jan 19 09:07 PM
Wright-Mitchell Jane	General Counsel	Jan 15	Option Exercise	2.03	2,500	5,075	4,062	Jan 19 06:29 PM
Hopfner Robert Lorne	Director	Jan 15	Sale	25.78	26,677	687,846	1,938,417	Jan 19 09:07 PM
Wright-Mitchell Jane	General Counsel	Jan 15	Sale	26.00	2,500	65,000	1,562	Jan 19 06:29 PM
Hopfner Robert Lorne	Director	Jan 14	Sale	25.88	14,918	386,078	1,965,094	Jan 19 09:07 PM
Hopfner Robert Lorne	Director	Jan 13	Sale	25.95	29,110	755,313	1,980,012	Jan 13 08:39 PM
Hopfner Robert Lorne	Director	Jan 12	Sale	26.38	18,567	489,871	2,009,122	Jan 13 08:39 PM
Sauer Paul	SVP Process Dev, Manufacturing	Jan 11	Option Exercise	1.79	2,500	4,475	80,399	Jan 12 09:43 PM
Hopfner Robert Lorne	Director	Jan 11	Sale	26.45	49,666	1,313,764	2,027,689	Jan 13 08:39 PM
Sauer Paul	SVP Process Dev, Manufacturing	Jan 11	Sale	26.21	2,500	65,527	77,899	Jan 12 09:43 PM
Hopfner Robert Lorne	Director	Jan 08	Sale	26.58	40,612	1,079,549	2,077,355	Jan 08 05:17 PM
Hopfner Robert Lorne	Director	Jan 07	Sale	28.27	47,580	1,344,887	2,117,967	Jan 08 05:17 PM
Hopfner Robert Lorne	Director	Jan 06	Sale	29.53	57,420	1,695,841	2,165,547	Jan 08 05:17 PM
Fairman Jeff	VP, Research	Dec 29	Option Exercise	1.79	740	1,325	1,408	Dec 30 08:26 PM
PICKERING GRANT	President & CEO	Dec 28	Option Exercise	1.79	5,500	9,845	578,691	Dec 29 06:01 PM
PICKERING GRANT	President & CEO	Dec 21	Option Exercise	1.79	15,000	26,850	588,191	Dec 22 08:44 PM
PICKERING GRANT	President & CEO	Dec 21	Sale	28.88	15,000	433,141	573,191	Dec 22 08:44 PM
TPG Group Holdings (SBS) Advis	Former 10% Owner	Dec 15	Sale	32.50	81,979	2,664,691	5,074,574	Dec 17 07:13 PM
RA CAPITAL MANAGEMENT, L.P.	10% Owner	Oct 08	Sale	50.69	167,661	8,498,065	5,001,593	Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.	10% Owner	Oct 07	Sale	50.95	98,597	5,023,527	5,169,254	Oct 09 04:22 PM
RA CAPITAL MANAGEMENT, L.P.	10% Owner	Sep 30	Sale	50.27	124,656	6,265,871	5,283,818	Oct 01 05:25 PM
RA CAPITAL MANAGEMENT, L.P.	10% Owner	Sep 29	Sale	52.08	80,707	4,202,987	5,408,474	Oct 01 05:25 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience